COSMOS Pharmaceutical Corporation (TYO:3349)

COSMOS Pharmaceutical Revenue

In the fiscal year ending May 31, 2026, COSMOS Pharmaceutical had annual revenue of 1.10T JPY with 8.72% growth. COSMOS Pharmaceutical had revenue of 289.20B in the quarter ending May 31, 2026, with 11.61% growth.

• Revenue: 1.10T
• Revenue Growth: +8.72%
• P/S Ratio: 0.46
• Revenue / Employee: 192.61M
• Employees: 5,709
• Market Cap: 505.90B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
May 31, 2026	1.10T	88.19B	8.72%
May 31, 2025	1.01T	46.40B	4.81%
May 31, 2024	964.99B	137.29B	16.59%
May 31, 2023	827.70B	72.28B	9.57%
May 31, 2022	755.41B	28.99B	3.99%

Data Source: S&P Global Market Intelligence Last updated: May 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 29, 2026

Data Sources Report a data error